<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37605232</PMID><DateCompleted><Year>2023</Year><Month>08</Month><Day>23</Day></DateCompleted><DateRevised><Year>2023</Year><Month>11</Month><Day>21</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1471-2458</ISSN><JournalIssue CitedMedium="Internet"><Volume>23</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Aug</Month><Day>21</Day></PubDate></JournalIssue><Title>BMC public health</Title><ISOAbbreviation>BMC Public Health</ISOAbbreviation></Journal><ArticleTitle>Long-term health consequences among individuals with SARS-CoV-2 infection compared to individuals without infection: results of the population-based cohort study CoMoLo Follow-up.</ArticleTitle><Pagination><StartPage>1587</StartPage><MedlinePgn>1587</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1587</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12889-023-16524-8</ELocationID><Abstract><AbstractText Label="BACKGROUND">Most of the previous studies on health sequelae of COVID-19 are uncontrolled cohorts and include a relatively short follow-up. This population-based multi-center cohort study examined health consequences among individuals about 1 to 1.5&#xa0;years after SARS-CoV-2 infection compared with non-infected.</AbstractText><AbstractText Label="METHODS">The study population consisted of adults (&#x2265;&#x2009;18&#xa0;years) from four municipalities particularly affected by the COVID-19 pandemic in the year 2020 who completed a detailed follow-up questionnaire on health-related topics. Exposure was the SARS-CoV-2 infection status (based on IgG antibodies, PCR test, or physician-diagnosis of COVID-19) at baseline (May to December 2020). Outcomes assessed at follow-up (October 2021 to January 2022; mean: 452&#xa0;days) included recurrent or persistent health complaints, incident diseases, health-related quality of life (PROMIS-29), subjective health, and subjective memory impairment. Logistic and linear regression models were adjusted for baseline sociodemographic and lifestyle characteristics (age, sex, municipality, education, smoking, body mass index), pre-existing health conditions (chronic disease/health problem, health-related activity limitation, depressive/anxiety disorder), and follow-up time.</AbstractText><AbstractText Label="RESULTS">Among 4817 participants, 350 had a SARS-CoV-2 infection at baseline and 4467 had no infection at baseline or during follow-up. Those with an infection statistically significantly more often reported 7 out of 18 recurrent or persistent health complaints at follow-up: smell/taste disorders (12.8% vs. 3.4%, OR 4.11), shortness of breath (23.0% vs. 9.5%, 3.46), pain when breathing (4.7% vs. 1.9%, 2.36), fatigue (36.9% vs. 26.1%, 1.76), weakness in legs (12.8% vs. 7.8%, 1.93), myalgia/joint pain (21.9% vs. 15.1%, 1.53) and cough (30.8% vs. 24.8%, 1.34) and 3 out of 6 groups of incident diseases: liver/kidney (2.7% vs. 0.9%, 3.70), lung (3.2% vs. 1.1%, 3.50) and cardiovascular/metabolic (6.5% vs. 4.0%, 1.68) diseases. Those with an infection were significantly more likely to report poor subjective health (19.3% vs. 13.0%, 1.91), memory impairment (25.7% vs. 14.3%, 2.27), and worse mean scores on fatigue and physical function domains of PROMIS-29 than non-infected.</AbstractText><AbstractText Label="CONCLUSION">Even after more than one year, individuals with SARS-CoV-2 infection showed an increased risk of various health complaints, functional limitations, and worse subjective well-being, pointing toward profound health consequences of SARS-CoV-2 infection relevant for public health.</AbstractText><CopyrightInformation>&#xa9; 2023. BioMed Central Ltd., part of Springer Nature.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Heidemann</LastName><ForeName>Christin</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Epidemiology and Health Monitoring, Robert Koch Institute, Berlin, Germany. heidemannc@rki.de.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sarganas</LastName><ForeName>Giselle</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Epidemiology and Health Monitoring, Robert Koch Institute, Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Du</LastName><ForeName>Yong</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Epidemiology and Health Monitoring, Robert Koch Institute, Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gaertner</LastName><ForeName>Beate</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Epidemiology and Health Monitoring, Robert Koch Institute, Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Poethko-M&#xfc;ller</LastName><ForeName>Christina</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Epidemiology and Health Monitoring, Robert Koch Institute, Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cohrdes</LastName><ForeName>Caroline</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Epidemiology and Health Monitoring, Robert Koch Institute, Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schmidt</LastName><ForeName>Sein</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Clinical Study Center, Berlin Institute of Health at Charit&#xe9; - Universit&#xe4;tsmedizin Berlin, Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Schlaud</LastName><ForeName>Martin</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Epidemiology and Health Monitoring, Robert Koch Institute, Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Scheidt-Nave</LastName><ForeName>Christa</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Epidemiology and Health Monitoring, Robert Koch Institute, Berlin, Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>08</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Public Health</MedlineTA><NlmUniqueID>100968562</NlmUniqueID><ISSNLinking>1471-2458</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011788" MajorTopicYN="N">Quality of Life</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005221" MajorTopicYN="N">Fatigue</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Fatigue</Keyword><Keyword MajorTopicYN="N">Follow-up</Keyword><Keyword MajorTopicYN="N">Health-related quality of life</Keyword><Keyword MajorTopicYN="N">Long COVID</Keyword><Keyword MajorTopicYN="N">Patient-reported outcomes</Keyword><Keyword MajorTopicYN="N">Post COVID</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">Subjective health</Keyword><Keyword MajorTopicYN="N">Symptoms</Keyword></KeywordList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>4</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>8</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>8</Month><Day>23</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>8</Month><Day>22</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>8</Month><Day>22</Day><Hour>0</Hour><Minute>21</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>8</Month><Day>21</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37605232</ArticleId><ArticleId IdType="pmc">PMC10440884</ArticleId><ArticleId IdType="doi">10.1186/s12889-023-16524-8</ArticleId><ArticleId IdType="pii">10.1186/s12889-023-16524-8</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Soriano JB, Murthy S, Marshall JC, Relan P, Diaz JV, W. H. O Clinical case definition working group on post-COVID-19 condition a clinical case definition of post-COVID-19 condition by a Delphi consensus. Lancet Infect Dis. 2022;22(4):e102&#x2013;e7. doi: 10.1016/S1473-3099(21)00703-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(21)00703-9</ArticleId><ArticleId IdType="pmc">PMC8691845</ArticleId><ArticleId IdType="pubmed">34951953</ArticleId></ArticleIdList></Reference><Reference><Citation>Hallek M, Adorjan K, Behrends U, Ertl G, Suttorp N, Lehmann C. Post-COVID syndrome. Dtsch Arztebl Int. 2023;120(4):48&#x2013;55.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10060997</ArticleId><ArticleId IdType="pubmed">36633452</ArticleId></ArticleIdList></Reference><Reference><Citation>Choutka J, Jansari V, Hornig M, Iwasaki A. Unexplained post-acute infection syndromes. Nat Med. 2022;28(5):911&#x2013;923. doi: 10.1038/s41591-022-01810-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01810-6</ArticleId><ArticleId IdType="pubmed">35585196</ArticleId></ArticleIdList></Reference><Reference><Citation>Callard F, Perego E. How and why patients made long Covid. Soc Sci Med. 2021;268:113426. doi: 10.1016/j.socscimed.2020.113426.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.socscimed.2020.113426</ArticleId><ArticleId IdType="pmc">PMC7539940</ArticleId><ArticleId IdType="pubmed">33199035</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization. A clinical case definition of post COVID-19 condition by a Delphi consensus, 6 October 2021. https://www.who.int/publications/i/item/WHO-2019-nCoV-Post_COVID-19_condition-Clinical_case_definition-2021.1. Accessed 15 Aug 2022.</Citation></Reference><Reference><Citation>National Institute for Health and Care Excellence (NICE). COVID-19 Rapid Guideline: Managing the Long-term Effects of COVID-19 (1.20 published on 03.11.2022). https://www.nice.org.uk/guidance/ng188. Accessed 21 April 2023.</Citation><ArticleIdList><ArticleId IdType="pubmed">33555768</ArticleId></ArticleIdList></Reference><Reference><Citation>AWMF. S1-Leitlinie Post-COVID/Long-COVID. https://register.awmf.org/de/leitlinien/detail/020-027. Accessed 29 Jan 2023.</Citation></Reference><Reference><Citation>Fernandez-de-Las-Penas C, Martin-Guerrero JD, Navarro-Pardo E, Rodriguez-Jimenez J, Pellicer-Valero OJ. Post-COVID functional limitations on daily living activities are associated with symptoms experienced at the acute phase of SARS-CoV-2 infection and internal care unit admission: a multicenter study. J Infect. 2022;84(2):248&#x2013;288. doi: 10.1016/j.jinf.2021.08.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2021.08.009</ArticleId><ArticleId IdType="pmc">PMC8349395</ArticleId><ArticleId IdType="pubmed">34375711</ArticleId></ArticleIdList></Reference><Reference><Citation>Bahmer T, Borzikowsky C, Lieb W, Horn A, Krist L, Fricke J, et al. Severity, predictors and clinical correlates of post-COVID syndrome (PCS) in Germany: a prospective, multi-centre, population-based cohort study. EClinicalMedicine. 2022;51:101549. doi: 10.1016/j.eclinm.2022.101549.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2022.101549</ArticleId><ArticleId IdType="pmc">PMC9289961</ArticleId><ArticleId IdType="pubmed">35875815</ArticleId></ArticleIdList></Reference><Reference><Citation>Greer N, Bart B, Billington CJ, Diem SJ, Ensrud KE, Kaka A, et al. COVID-19 postacute care major organ damage: a systematic review. BMJ Open. 2022;12(8):e061245. doi: 10.1136/bmjopen-2022-061245.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2022-061245</ArticleId><ArticleId IdType="pmc">PMC9412042</ArticleId><ArticleId IdType="pubmed">36002211</ArticleId></ArticleIdList></Reference><Reference><Citation>Wrona M, Skrypnik D. New-onset diabetes mellitus, hypertension, dyslipidaemia as sequelae of COVID-19 infection-systematic review. Int J Environ Res Public Health. 2022;19(20):13280. doi: 10.3390/ijerph192013280.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph192013280</ArticleId><ArticleId IdType="pmc">PMC9602450</ArticleId><ArticleId IdType="pubmed">36293857</ArticleId></ArticleIdList></Reference><Reference><Citation>Global Burden of Disease Long Covid Collaborators Estimated global proportions of individuals with persistent fatigue, cognitive, and respiratory symptom clusters following symptomatic COVID-19 in 2020 and 2021. JAMA. 2022;328(16):1604&#x2013;1615. doi: 10.1001/jama.2022.18931.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2022.18931</ArticleId><ArticleId IdType="pmc">PMC9552043</ArticleId><ArticleId IdType="pubmed">36215063</ArticleId></ArticleIdList></Reference><Reference><Citation>Franco JVA, Garegnani LI, Oltra GV, Metzendorf MI, Trivisonno LF, Sgarbossa N, et al. Long-term health symptoms and sequelae following SARS-CoV-2 infection: an evidence map. Int J Environ Res Public Health. 2022;19(16):9915. doi: 10.3390/ijerph19169915.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph19169915</ArticleId><ArticleId IdType="pmc">PMC9408764</ArticleId><ArticleId IdType="pubmed">36011562</ArticleId></ArticleIdList></Reference><Reference><Citation>Santos-Hovener C, Busch MA, Koschollek C, Schlaud M, Hoebel J, Hoffmann R, et al. Seroepidemiological study on the spread of SARS-CoV-2 in populations in especially affected areas in Germany - study protocol of the CORONA-MONITORING lokal study. J Health Monit. 2020;5(Suppl 5):2&#x2013;16.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8734078</ArticleId><ArticleId IdType="pubmed">35146295</ArticleId></ArticleIdList></Reference><Reference><Citation>Santos-Hovener C, Neuhauser HK, Rosario AS, Busch M, Schlaud M, Hoffmann R, et al. Serology- and PCR-based cumulative incidence of SARS-CoV-2 infection in adults in a successfully contained early hotspot (CoMoLo study), Germany, May to June 2020. Euro Surveill. 2020;25(47):2001752. doi: 10.2807/1560-7917.ES.2020.25.47.2001752.</Citation><ArticleIdList><ArticleId IdType="doi">10.2807/1560-7917.ES.2020.25.47.2001752</ArticleId><ArticleId IdType="pmc">PMC7693167</ArticleId><ArticleId IdType="pubmed">33243353</ArticleId></ArticleIdList></Reference><Reference><Citation>Heidemann C, Reitzle L, Schmidt C, Fuchs J, Prutz F, Scheidt-Nave C. Non-utilisation of health care services during the COVID-19 pandemic: results of the CoMoLo study. J Health Monit. 2022;7(Suppl 1):2&#x2013;17.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8939005</ArticleId><ArticleId IdType="pubmed">35356069</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuhauser H, Buttmann-Schweiger N, Ellert U, Fiebig J, H&#xf6;vener C, Offergeld R, et al. Seroepidemiologische Studien zu SARS-CoV-2 in Stichproben der Allgemeinbev&#xf6;lkerung und bei Blutspenderinnen und Blutspendern in Deutschland &#x2013; Ergebnisse bis August 2021. https://edoc.rki.de/handle/176904/8743. Accessed 21 Apr 2023.</Citation></Reference><Reference><Citation>Jessen F, Wiese B, Cvetanovska G, Fuchs A, Kaduszkiewicz H, Kolsch H, et al. Patterns of subjective memory impairment in the elderly: association with memory performance. Psychol Med. 2007;37(12):1753&#x2013;1762. doi: 10.1017/S0033291707001122.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S0033291707001122</ArticleId><ArticleId IdType="pubmed">17623488</ArticleId></ArticleIdList></Reference><Reference><Citation>Alonso J, Bartlett SJ, Rose M, Aaronson NK, Chaplin JE, Efficace F, et al. The case for an international patient-reported outcomes measurement information system (PROMIS(R)) initiative. Health Qual Life Outcomes. 2013;11:210. doi: 10.1186/1477-7525-11-210.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1477-7525-11-210</ArticleId><ArticleId IdType="pmc">PMC3879205</ArticleId><ArticleId IdType="pubmed">24359143</ArticleId></ArticleIdList></Reference><Reference><Citation>Fischer F, Gibbons C, Coste J, Valderas JM, Rose M, Leplege A. Measurement invariance and general population reference values of the PROMIS profile 29 in the UK, France, and Germany. Qual Life Res. 2018;27(4):999&#x2013;1014. doi: 10.1007/s11136-018-1785-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11136-018-1785-8</ArticleId><ArticleId IdType="pubmed">29350345</ArticleId></ArticleIdList></Reference><Reference><Citation>Patient-Reported Outcomes Measurement Information System. PROMIS ADULT PROFILE INSTRUMENTS - A brief guide to the PROMIS&#xae; Profile instruments for adult respondents. https://staging.healthmeasures.net/images/PROMIS/manuals/PROMIS_Adult_Profile_Scoring_Manual.pdf. Accessed 29 Sep 2022.</Citation></Reference><Reference><Citation>Statistical Office of the European Union (Eurostat). International Standard Classification of Education (ISCED). https://ec.europa.eu/eurostat/statistics-explained/index.php?title=International_Standard_Classification_of_Education_(ISCED). Accessed 15 Aug 2022.</Citation></Reference><Reference><Citation>Cox B, van Oyen H, Cambois E, Jagger C, le Roy S, Robine JM, et al. The reliability of the minimum European health module. Int J Public Health. 2009;54(2):55&#x2013;60. doi: 10.1007/s00038-009-7104-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00038-009-7104-y</ArticleId><ArticleId IdType="pubmed">19183846</ArticleId></ArticleIdList></Reference><Reference><Citation>Kroenke K, Spitzer RL, Williams JB, Lowe B. An ultra-brief screening scale for anxiety and depression: the PHQ-4. Psychosomatics. 2009;50(6):613&#x2013;621.</Citation><ArticleIdList><ArticleId IdType="pubmed">19996233</ArticleId></ArticleIdList></Reference><Reference><Citation>Miettinen OS. Proportion of disease caused or prevented by a given exposure, trait or intervention. Am J Epidemiol. 1974;99(5):325&#x2013;332. doi: 10.1093/oxfordjournals.aje.a121617.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/oxfordjournals.aje.a121617</ArticleId><ArticleId IdType="pubmed">4825599</ArticleId></ArticleIdList></Reference><Reference><Citation>van Buuren S. Multiple imputation of discrete and continuous data by fully conditional specification. Stat Methods Med Res. 2007;16(3):219&#x2013;242. doi: 10.1177/0962280206074463.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0962280206074463</ArticleId><ArticleId IdType="pubmed">17621469</ArticleId></ArticleIdList></Reference><Reference><Citation>O'Mahoney LL, Routen A, Gillies C, Ekezie W, Welford A, Zhang A, et al. The prevalence and long-term health effects of long Covid among hospitalised and non-hospitalised populations: a systematic review and meta-analysis. EClinicalMedicine. 2023;55:101762. doi: 10.1016/j.eclinm.2022.101762.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2022.101762</ArticleId><ArticleId IdType="pmc">PMC9714474</ArticleId><ArticleId IdType="pubmed">36474804</ArticleId></ArticleIdList></Reference><Reference><Citation>Nittas V, Gao M, West EA, Ballouz T, Menges D, Wulf Hanson S, et al. Long COVID through a public health lens: an umbrella review. Public Health Rev. 2022;43:1604501. doi: 10.3389/phrs.2022.1604501.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/phrs.2022.1604501</ArticleId><ArticleId IdType="pmc">PMC8963488</ArticleId><ArticleId IdType="pubmed">35359614</ArticleId></ArticleIdList></Reference><Reference><Citation>Caspersen IH, Magnus P, Trogstad L. Excess risk and clusters of symptoms after COVID-19 in a large Norwegian cohort. Eur J Epidemiol. 2022;37(5):539&#x2013;548. doi: 10.1007/s10654-022-00847-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10654-022-00847-8</ArticleId><ArticleId IdType="pmc">PMC8872922</ArticleId><ArticleId IdType="pubmed">35211871</ArticleId></ArticleIdList></Reference><Reference><Citation>Thaweethai T, Jolley SE, Karlson EW, Levitan EB, Levy B, McComsey GA, et al. Development of a definition of postacute sequelae of SARS-CoV-2 infection. JAMA. 2023;329(22):1934&#x2013;1946. doi: 10.1001/jama.2023.8823.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2023.8823</ArticleId><ArticleId IdType="pmc">PMC10214179</ArticleId><ArticleId IdType="pubmed">37278994</ArticleId></ArticleIdList></Reference><Reference><Citation>Peter RS, Nieters A, Krausslich HG, Brockmann SO, Gopel S, Kindle G, et al. Post-acute sequelae of covid-19 six to 12 months after infection: population based study. BMJ. 2022;379:e071050. doi: 10.1136/bmj-2022-071050.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj-2022-071050</ArticleId><ArticleId IdType="pmc">PMC9557001</ArticleId><ArticleId IdType="pubmed">36229057</ArticleId></ArticleIdList></Reference><Reference><Citation>Hartung TJ, Neumann C, Bahmer T, Chaplinskaya-Sobol I, Endres M, Geritz J, et al. Fatigue and cognitive impairment after COVID-19: a prospective multicentre study. EClinicalMedicine. 2022;53:101651. doi: 10.1016/j.eclinm.2022.101651.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2022.101651</ArticleId><ArticleId IdType="pmc">PMC9482331</ArticleId><ArticleId IdType="pubmed">36133318</ArticleId></ArticleIdList></Reference><Reference><Citation>de Oliveira Almeida K, Nogueira Alves IG, de Queiroz RS, de Castro MR, Gomes VA, Santos Fontoura FC, et al. A systematic review on physical function, activities of daily living and health-related quality of life in COVID-19 survivors. Chronic Illn. 2022;19:279. doi: 10.1177/17423953221089309.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/17423953221089309</ArticleId><ArticleId IdType="pmc">PMC9006095</ArticleId><ArticleId IdType="pubmed">35404175</ArticleId></ArticleIdList></Reference><Reference><Citation>Ballering AV, van Zon SKR, Olde Hartman TC, Rosmalen JGM, Lifelines Corona Research I Persistence of somatic symptoms after COVID-19 in the Netherlands: an observational cohort study. Lancet. 2022;400(10350):452&#x2013;61. doi: 10.1016/S0140-6736(22)01214-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(22)01214-4</ArticleId><ArticleId IdType="pmc">PMC9352274</ArticleId><ArticleId IdType="pubmed">35934007</ArticleId></ArticleIdList></Reference><Reference><Citation>Kubota T, Kuroda N, Sone D. Neuropsychiatric aspects of long COVID: A comprehensive review. Psychiatry Clin Neurosci. 2023;77(2):84&#x2013;93. doi: 10.1111/pcn.13508.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/pcn.13508</ArticleId><ArticleId IdType="pmc">PMC10108156</ArticleId><ArticleId IdType="pubmed">36385449</ArticleId></ArticleIdList></Reference><Reference><Citation>Velichkovsky BB, Razvaliaeva AY, Khlebnikova AA, Manukyan PA, Kasatkin VN. Attention and memory after COVID-19 as measured by neuropsychological tests: systematic review and meta-analysis. Acta Psychol (Amst) 2023;233:103838. doi: 10.1016/j.actpsy.2023.103838.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.actpsy.2023.103838</ArticleId><ArticleId IdType="pmc">PMC9834202</ArticleId><ArticleId IdType="pubmed">36657196</ArticleId></ArticleIdList></Reference><Reference><Citation>Wion RK, Hill NL, Reed Bell T, Mogle J, Yates J, Bhang I. The role of cognitive self-report measure type in predicting cognitive decline among older adults: a systematic review. J Geriatr Psychiatry Neurol. 2022;35(4):487&#x2013;511. doi: 10.1177/08919887211023591.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/08919887211023591</ArticleId><ArticleId IdType="pmc">PMC8688580</ArticleId><ArticleId IdType="pubmed">34151643</ArticleId></ArticleIdList></Reference><Reference><Citation>Pike KE, Cavuoto MG, Li L, Wright BJ, Kinsella GJ. Subjective cognitive decline: level of risk for future dementia and mild cognitive impairment, a meta-analysis of longitudinal studies. Neuropsychol Rev. 2022;32(4):703&#x2013;735. doi: 10.1007/s11065-021-09522-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11065-021-09522-3</ArticleId><ArticleId IdType="pubmed">34748154</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang Y, Pinto MD, Borelli JL, Asgari Mehrabadi M, Abrahim HL, Dutt N, et al. COVID symptoms, symptom clusters, and predictors for becoming a long-hauler looking for clarity in the haze of the pandemic. Clin Nurs Res. 2022;31(8):1390&#x2013;1398. doi: 10.1177/10547738221125632.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/10547738221125632</ArticleId><ArticleId IdType="pmc">PMC9510954</ArticleId><ArticleId IdType="pubmed">36154716</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeng N, Zhao YM, Yan W, Li C, Lu QD, Liu L, et al. A systematic review and meta-analysis of long term physical and mental sequelae of COVID-19 pandemic: call for research priority and action. Mol Psychiatry. 2023;28(1):423&#x2013;433. doi: 10.1038/s41380-022-01614-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41380-022-01614-7</ArticleId><ArticleId IdType="pmc">PMC9168643</ArticleId><ArticleId IdType="pubmed">35668159</ArticleId></ArticleIdList></Reference><Reference><Citation>Shrestha AB, Mehta A, Pokharel P, Mishra A, Adhikari L, Shrestha S, et al. Long COVID Syndrome and cardiovascular manifestations: a systematic review and meta-analysis. Diagnostics (Basel) 2023;13(3):491. doi: 10.3390/diagnostics13030491.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/diagnostics13030491</ArticleId><ArticleId IdType="pmc">PMC9913936</ArticleId><ArticleId IdType="pubmed">36766599</ArticleId></ArticleIdList></Reference><Reference><Citation>Petersen EL, Gossling A, Adam G, Aepfelbacher M, Behrendt CA, Cavus E, et al. Multi-organ assessment in mainly non-hospitalized individuals after SARS-CoV-2 infection: the Hamburg City Health Study COVID programme. Eur Heart J. 2022;43(11):1124&#x2013;1137. doi: 10.1093/eurheartj/ehab914.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehab914</ArticleId><ArticleId IdType="pmc">PMC8755397</ArticleId><ArticleId IdType="pubmed">34999762</ArticleId></ArticleIdList></Reference><Reference><Citation>Peluso MJ, Deeks SG. Early clues regarding the pathogenesis of long-COVID. Trends Immunol. 2022;43(4):268&#x2013;270. doi: 10.1016/j.it.2022.02.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.it.2022.02.008</ArticleId><ArticleId IdType="pmc">PMC8901423</ArticleId><ArticleId IdType="pubmed">35272932</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis HE, McCorkell L, Vogel JM, Topol EJ. Long COVID: major findings, mechanisms and recommendations. Nat Rev Microbiol. 2023;21(3):133&#x2013;146. doi: 10.1038/s41579-022-00846-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-022-00846-2</ArticleId><ArticleId IdType="pmc">PMC9839201</ArticleId><ArticleId IdType="pubmed">36639608</ArticleId></ArticleIdList></Reference><Reference><Citation>Iwasaki A, Putrino D. Why we need a deeper understanding of the pathophysiology of long COVID. Lancet Infect Dis. 2023;23(4):393&#x2013;395. doi: 10.1016/S1473-3099(23)00053-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(23)00053-1</ArticleId><ArticleId IdType="pmc">PMC9928485</ArticleId><ArticleId IdType="pubmed">36967698</ArticleId></ArticleIdList></Reference><Reference><Citation>Littlefield KM, Watson RO, Schneider JM, Neff CP, Yamada E, Zhang M, et al. SARS-CoV-2-specific T cells associate with inflammation and reduced lung function in pulmonary post-acute sequalae of SARS-CoV-2. PLoS Pathog. 2022;18(5):e1010359. doi: 10.1371/journal.ppat.1010359.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1010359</ArticleId><ArticleId IdType="pmc">PMC9176759</ArticleId><ArticleId IdType="pubmed">35617421</ArticleId></ArticleIdList></Reference><Reference><Citation>Antonelli M, Pujol JC, Spector TD, Ourselin S, Steves CJ. Risk of long COVID associated with delta versus omicron variants of SARS-CoV-2. Lancet. 2022;399(10343):2263&#x2013;2264. doi: 10.1016/S0140-6736(22)00941-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(22)00941-2</ArticleId><ArticleId IdType="pmc">PMC9212672</ArticleId><ArticleId IdType="pubmed">35717982</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>